Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.
Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked ...
Ending Acquired Immune Deficiency Syndrome (AIDS) as a public health threat here by 2030 will take much effort as it will all around the world. The key, ...
With the local market share of its existing brands ranging from 25 percent to 100 percent, BFBIO has a strong portfolio of ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...